Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Emblem Positioned to be Disruptive in Medical Cannabis
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by deminimison Oct 11, 2017 4:45pm
78 Views
Post# 26801324

RE:RE:RE:Emblem Positioned to be Disruptive in Medical Cannabis

RE:RE:RE:Emblem Positioned to be Disruptive in Medical Cannabis I don't think it has anything to do with the fact that it is pain medication. As the article states, traditional pharmaceutical drugs (including pain drugs) typically take 5-10 years to develop, complete clinical trials and gain approval to sell. I imagine most of that time frame is dedicated to evaluating potential side effects. I presume the fact that the side effects of cannabis are already known is the reason why cannabis-based drugs can make it to market in a matter of months.

If this is all true, I think that rocket ship is going to be cleared for take off much sooner than I originally anticipated.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities